the potential of studying circulating plasma cells in multiple myeloma
Published 1 year ago • 97 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:02
circulating plasma cell levels as a prognostic biomarker in myeloma
-
2:28
b-cells and pre-plasma cells are important reservoirs responsible for relapse in multiple myeloma
-
3:05
identifying new therapeutic targets on the surfaceome of myeloma plasma cells with proteomics
-
2:20
the role of myeloma b-cells & pre-plasma cell progenitors in disease relapse following therapy
-
1:33
circulating tumor cells in multiple myeloma
-
3:03
what is plasma cell percentage and why is it measured in the bone marrow?
-
9:25
mgus diagnosis: a step-by-step approach
-
4:08
how can plasma cell leukemia be managed?
-
1:49
using flow cytometry to detect abnormal plasma cells in mgus & predict disease progression
-
0:59
defining the origins of multiple myeloma
-
3:00
current & emerging biomarkers in multiple myeloma
-
1:46
insights into mass spectrometry-based proteomics in multiple myeloma research
-
2:42
the value of circulating tumor cells for the staging of patients with ndmm
-
1:53
the future of multiple myeloma treatment
-
1:58
clonal hematopoiesis in multiple myeloma and implications for therapy
-
1:01
car-t: myeloma toxicities
-
1:05
the prognostic and potentially therapeutic value of liquid biopsy in multiple myeloma
-
7:38
bone marrow biopsy in patients with plasma cell disorders
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
2:44
myeloma qol through induction and maintenance
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
2:46
managing patients with high-risk myeloma